• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性高血压患者维生素D受体基因多态性与血浆肾素活性

Vitamin D receptor gene polymorphisms and plasma renin activity in essential hypertensive individuals.

作者信息

Cottone S, Guarino L, Arsena R, Scazzone C, Tornese F, Guarneri M, Guglielmo C, Bono A, Mulè G

机构信息

Nephrology and Hypertension Unit, Dipartimento Biomedico di Medicina Interna e Specialistica, Università di Palermo, Palermo, Italy.

Dipartimento di Biopatologia e Biotecnologie Mediche e Forensi, Università di Palermo, Palermo, Italy.

出版信息

J Hum Hypertens. 2015 Aug;29(8):483-7. doi: 10.1038/jhh.2014.113. Epub 2014 Dec 11.

DOI:10.1038/jhh.2014.113
PMID:25500899
Abstract

Several studies analyzed 25-hydroxyvitamin D (25[OH]D) and blood pressure (BP) relationship with mixed results. Moreover, a relationship between the risk of hypertension and vitamin D receptor (VDR) gene polymorphisms, FokI and BsmI, was reported. This study was aimed to analyze these relationships in essential hypertensive (EH) patients. Seventy-one EH patients, 18-75 years old, were enrolled. Patients underwent clinical BP, 24-h ambulatory BP monitoring, 25[OH]D and plasma renin activity (PRA) evaluations. FokI and BsmI VDR polymorphisms were analyzed and compared with those of 72 healthy controls. In EH patients, the median 25[OH]D levels were lower than 30 ng ml(-1). We found a significant negative correlation between 25[OH]D and 24-h systolic BP (r = -0.277, P = 0.043). This correlation persisted in backward stepwise multivariate analyses (β = -0.337; P = 0.022), after adjustment for age, gender, body mass index, glomerular filtration rate, and PRA. We did not observe statistically significant correlation between 25[OH]D and PRA. We compared the allelic frequencies and genotype distribution between patients and controls, and FokI and BsmI VDR polymorphisms were not associated either with hypertensive status or with PRA. Further wide studies are needed to clarify this relationship.

摘要

多项研究分析了25-羟维生素D(25[OH]D)与血压(BP)之间的关系,结果不一。此外,有报道称高血压风险与维生素D受体(VDR)基因多态性FokI和BsmI之间存在关联。本研究旨在分析原发性高血压(EH)患者中的这些关系。纳入了71例年龄在18至75岁之间的EH患者。患者接受了临床血压、24小时动态血压监测、25[OH]D和血浆肾素活性(PRA)评估。分析了FokI和BsmI VDR基因多态性,并与72名健康对照者的进行比较。在EH患者中,25[OH]D水平中位数低于30 ng/ml。我们发现25[OH]D与24小时收缩压之间存在显著负相关(r = -0.277,P = 0.043)。在对年龄、性别、体重指数、肾小球滤过率和PRA进行调整后,这种相关性在向后逐步多变量分析中仍然存在(β = -0.337;P = 0.022)。我们未观察到25[OH]D与PRA之间存在统计学显著相关性。我们比较了患者与对照者之间的等位基因频率和基因型分布,FokI和BsmI VDR基因多态性与高血压状态或PRA均无关联。需要进一步开展广泛研究以阐明这种关系。

相似文献

1
Vitamin D receptor gene polymorphisms and plasma renin activity in essential hypertensive individuals.原发性高血压患者维生素D受体基因多态性与血浆肾素活性
J Hum Hypertens. 2015 Aug;29(8):483-7. doi: 10.1038/jhh.2014.113. Epub 2014 Dec 11.
2
The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians.Fok1 维生素 D 受体基因多态性与白种人血浆肾素活性相关。
Clin Endocrinol (Oxf). 2011 Jun;74(6):783-90. doi: 10.1111/j.1365-2265.2011.03991.x.
3
Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder.维生素D受体基因多态性与自闭症谱系障碍儿童血清25-羟基维生素D水平的关联
Gene. 2016 Aug 22;588(2):109-14. doi: 10.1016/j.gene.2016.05.004. Epub 2016 May 4.
4
A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men.一项关于血浆维生素 D 代谢产物、维生素 D 受体基因多态性与男性高血压风险的前瞻性研究。
Eur J Nutr. 2013 Oct;52(7):1771-9. doi: 10.1007/s00394-012-0480-8. Epub 2012 Dec 21.
5
A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.一项关于血浆维生素D代谢物、维生素D受体基因多态性与前列腺癌的前瞻性研究。
PLoS Med. 2007 Mar;4(3):e103. doi: 10.1371/journal.pmed.0040103.
6
Influence of vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D on blood pressure in apparently healthy subjects.维生素D受体基因多态性和25-羟基维生素D对健康受试者血压的影响。
J Hypertens. 2003 Nov;21(11):2069-75. doi: 10.1097/01.hjh.0000098139.70956.21.
7
The effect of VDR gene polymorphisms and vitamin D level on blood pressure, risk of preeclampsia, gestational age, and body mass index.维生素 D 受体基因多态性和维生素 D 水平对血压、子痫前期风险、 gestational age、体重指数的影响。
J Cell Biochem. 2019 Apr;120(4):6441-6448. doi: 10.1002/jcb.27934. Epub 2018 Nov 11.
8
The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus.巴西系统性红斑狼疮患者维生素 D 受体基因 BsmI 和 FokI 多态性及血清 25-羟维生素 D 的作用。
Lupus. 2012 Jan;21(1):43-52. doi: 10.1177/0961203311421798. Epub 2011 Oct 12.
9
Vitamin D receptor polymorphisms in hypocalcemic vitamin D-resistant rickets carriers.低钙血症性维生素D抵抗性佝偻病携带者的维生素D受体基因多态性
Horm Res. 2007;67(4):179-83. doi: 10.1159/000097014. Epub 2006 Nov 13.
10
Evaluation of the correlation between serum levels of vitamin D and vitamin D receptor gene polymorphisms in an Egyptian population.埃及人群中血清维生素D水平与维生素D受体基因多态性之间的相关性评估。
Int J Dermatol. 2016 Dec;55(12):1329-1335. doi: 10.1111/ijd.13363. Epub 2016 Jul 15.

引用本文的文献

1
Association between vitamin D receptor gene polymorphism and essential hypertension: An updated systematic review, meta-analysis, and meta-regression.维生素D受体基因多态性与原发性高血压之间的关联:一项更新的系统评价、荟萃分析和Meta回归分析
PLoS One. 2024 Dec 23;19(12):e0314886. doi: 10.1371/journal.pone.0314886. eCollection 2024.
2
Fok I and Bsm I gene polymorphism of vitamin D receptor and essential hypertension: a mechanistic link.维生素D受体的Fok I和Bsm I基因多态性与原发性高血压:一种机制联系。
Clin Hypertens. 2023 Feb 15;29(1):5. doi: 10.1186/s40885-022-00229-y.
3
The Association Between FokI Vitamin D Receptor Polymorphisms With Metabolic Syndrome Among Pregnant Arab Women.

本文引用的文献

1
Common genetic variations in the vitamin D pathway in relation to blood pressure.维生素D代谢途径中与血压相关的常见基因变异。
Am J Hypertens. 2014 Nov;27(11):1387-95. doi: 10.1093/ajh/hpu049. Epub 2014 Mar 31.
2
A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men.一项关于血浆维生素 D 代谢产物、维生素 D 受体基因多态性与男性高血压风险的前瞻性研究。
Eur J Nutr. 2013 Oct;52(7):1771-9. doi: 10.1007/s00394-012-0480-8. Epub 2012 Dec 21.
3
Relationship between vitamin D deficiency and nondipper hypertension.
FokI 维生素 D 受体多态性与阿拉伯孕妇代谢综合征的关联。
Front Endocrinol (Lausanne). 2022 Feb 24;13:844472. doi: 10.3389/fendo.2022.844472. eCollection 2022.
4
Meta-Analysis of the Association Between the rs228570 Vitamin D Receptor Gene Polymorphism and Arterial Hypertension Risk.rs228570 维生素 D 受体基因多态性与动脉高血压风险关联的荟萃分析。
Adv Nutr. 2020 Sep 1;11(5):1211-1220. doi: 10.1093/advances/nmaa076.
维生素 D 缺乏与非杓型高血压的关系。
Clin Exp Hypertens. 2013;35(1):45-9. doi: 10.3109/10641963.2012.689045. Epub 2012 May 17.
4
Risk conferred by FokI polymorphism of vitamin D receptor (VDR) gene for essential hypertension.维生素D受体(VDR)基因FokI多态性对原发性高血压的风险。
Indian J Hum Genet. 2011 Sep;17(3):201-6. doi: 10.4103/0971-6866.92104.
5
[Vitamin D and hypertension].[维生素D与高血压]
Med Clin (Barc). 2012 Apr 14;138(9):397-401. doi: 10.1016/j.medcli.2011.04.015. Epub 2011 Jun 23.
6
The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians.Fok1 维生素 D 受体基因多态性与白种人血浆肾素活性相关。
Clin Endocrinol (Oxf). 2011 Jun;74(6):783-90. doi: 10.1111/j.1365-2265.2011.03991.x.
7
Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans.血浆 25-羟维生素 D 与人体肾素-血管紧张素系统的调节。
Hypertension. 2010 May;55(5):1283-8. doi: 10.1161/HYPERTENSIONAHA.109.148619. Epub 2010 Mar 29.
8
Role of vitamin D in blood pressure homeostasis.维生素 D 在血压稳态中的作用。
Am J Ther. 2010 Nov-Dec;17(6):e221-9. doi: 10.1097/MJT.0b013e3181d16999.
9
Association of low serum 25-hydroxyvitamin D levels and high arterial blood pressure in the elderly.老年人血清 25-羟维生素 D 水平低与动脉血压高的相关性。
Nephrol Dial Transplant. 2010 Feb;25(2):503-9. doi: 10.1093/ndt/gfp470. Epub 2009 Sep 11.
10
A new equation to estimate glomerular filtration rate.一种估算肾小球滤过率的新公式。
Ann Intern Med. 2009 May 5;150(9):604-12. doi: 10.7326/0003-4819-150-9-200905050-00006.